Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

2.1K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.1K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

442
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
442
Cross-bridge Cycle01:26

Cross-bridge Cycle

119.9K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
119.9K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

1.3K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.3K
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

2.6K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
2.6K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiple spinal muscular atrophy disease-modifying effects of a Hspa8G470R synaptic chaperone variant.

Brain : a journal of neurology·2026
Same author

Cardiac defects in spinal muscular atrophy and the role of SMN in cardiomyocyte homeostasis.

bioRxiv : the preprint server for biology·2026
Same author

Protein-stabilizing and neurotransmission-potentiating activities of a synaptic chaperone modify spinal muscular atrophy in model mice.

bioRxiv : the preprint server for biology·2026
Same author

Bullying experiences of youth with neuromuscular disorders and their well-being: A survey study.

Journal of neuromuscular diseases·2025
Same author

The Role of Mesenchymal Stromal Cells in the Treatment of Bronchopulmonary Dysplasia: A Multi-Prong Approach for a Heterogeneous Disease.

Comprehensive Physiology·2025
Same author

Cell-based therapies in preclinical models of necrotizing enterocolitis: a systematic review and meta-analysis.

Stem cells translational medicine·2025

Related Experiment Video

Updated: Nov 3, 2025

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

11.9K

Metabolic Dysfunction in Spinal Muscular Atrophy.

Marc-Olivier Deguise1,2,3, Lucia Chehade1,3,4, Rashmi Kothary1,3,4,5,6

  • 1Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada.

International Journal of Molecular Sciences
|June 2, 2021
PubMed
Summary

Spinal muscular atrophy (SMA) research reveals gastrointestinal, metabolic, and endocrine dysfunctions. These may impact disease severity, but their link to denervation requires further investigation.

Keywords:
amino acidsbody compositionfatgastrointestinalglucosemetabolismnutrition

More Related Videos

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
08:19

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

2.6K
Measuring Neuromuscular Junction Functionality
10:40

Measuring Neuromuscular Junction Functionality

Published on: August 6, 2017

18.3K

Related Experiment Videos

Last Updated: Nov 3, 2025

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

11.9K
Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
08:19

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

2.6K
Measuring Neuromuscular Junction Functionality
10:40

Measuring Neuromuscular Junction Functionality

Published on: August 6, 2017

18.3K

Area of Science:

  • Neurology
  • Genetics
  • Metabolism

Background:

  • Spinal muscular atrophy (SMA) is a severe genetic disorder affecting motor neurons.
  • Advances in treatment have improved patient outcomes, but the underlying mechanisms are not fully understood.
  • Emerging evidence suggests metabolic and endocrine disruptions contribute to SMA's phenotype.

Purpose of the Study:

  • To review current research on metabolism-related defects in SMA.
  • To discuss the potential impact of these defects on disease traits.
  • To compare SMA's metabolic features with other motor neuron disorders.

Main Methods:

  • Literature review of metabolism-related research in SMA.
  • Analysis of findings on body composition, gastrointestinal, and hormonal regulation.
  • Comparative analysis with other neurological disorders.

Main Results:

  • SMA patients exhibit disrupted body composition, gastrointestinal function, and metabolic regulation (fatty acid, glucose, amino acid).
  • Hormonal regulation is also affected in SMA.
  • The precise role of these metabolic changes and their relation to denervation is unclear.

Conclusions:

  • Metabolic and endocrine defects are increasingly recognized in SMA.
  • These disruptions may significantly influence the clinical presentation of SMA.
  • Further research is needed to differentiate SMA-specific metabolic changes from those secondary to denervation.